We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$296M
Cap. Flow
+$131M
Cap. Flow %
4.52%
Top 10 Hldgs %
24.94%
Holding
240
New
84
Increased
29
Reduced
44
Closed
78

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$90.9M
2
FDX icon
FedEx
FDX
+$83M
3
HUB.B
HUBBELL INC CL-B
HUB.B
+$78.8M
4
BAX icon
Baxter International
BAX
+$75.4M
5
PPG icon
PPG Industries
PPG
+$64.5M

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$54.1M
2
HUN icon
Huntsman Corp
HUN
+$52.6M
3
AGN
Allergan Inc
AGN
+$50.5M
4
GILD icon
Gilead Sciences
GILD
+$48.4M
5
GRMN
Garmin
GRMN
+$39.9M

Sector Composition

Rank Sector Weight
1 Technology 19.08%
2 Healthcare 14.39%
3 Consumer Discretionary 11.4%
4 Industrials 10.61%
5 Financials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRQR icon
151
ProQR Therapeutics
PRQR
$243M
$656K 0.02%
30,000
-60,000
-67% -$1.24M
SC
152
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$582K 0.02%
25,099
-401,590
-94% -$8.47M
BLUE
153
DELISTED
bluebird bio
BLUE
$555K 0.02%
+355
New +$468K
VIRX
154
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$489K 0.02%
+952
New +$480K
ABUS icon
155
Arbutus Biopharma
ABUS
$865M
$349K 0.01%
+20,000
New +$410K
RPRX
156
DELISTED
Repros Therapeutics Inc.
RPRX
$343K 0.01%
+40,000
New +$358K
VANI icon
157
Vivani Medical
VANI
$110M
$128K ﹤0.01%
+417
New +$116K
AAP icon
158
Advance Auto Parts
AAP
$3.37B
– –
-152,067
Closed -$24.2M
AAPL icon
159
Apple
AAPL
$4.89T
– –
-403,152
Closed -$11.1M
ALTO icon
160
Alto Ingredients
ALTO
$360M
– –
-572,021
Closed -$5.91M
AON icon
161
Aon
AON
$77.3B
– –
-162,943
Closed -$15.5M
AVDL
162
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-21,497
Closed -$368K
AVT icon
163
Avnet
AVT
$7.33B
– –
-224,799
Closed -$9.67M
AXP icon
164
American Express
AXP
$223B
– –
-115,154
Closed -$10.7M
AZN icon
165
AstraZeneca
AZN
$263B
– –
-201,565
Closed -$14.2M
BIIB icon
166
Biogen
BIIB
$29.9B
– –
-40,313
Closed -$13.7M
BNY
167
Bank of New York Mellon
BNY
$108B
– –
-145,581
Closed -$5.91M
BMRN icon
168
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-20,000
Closed -$1.81M
CCEP icon
169
Coca-Cola Europacific Partners
CCEP
$46.5B
– –
-718,970
Closed -$31.8M
CCK icon
170
Crown Holdings
CCK
$12.8B
– –
-86,996
Closed -$4.43M
CF icon
171
CF Industries
CF
$19.2B
– –
-100,000
Closed -$5.45M
CPA icon
172
Copa Holdings
CPA
$5.56B
– –
-18,969
Closed -$1.97M
CSL icon
173
Carlisle Companies
CSL
$13.6B
– –
-56,281
Closed -$5.08M
CSTM icon
174
Constellium
CSTM
$3.96B
– –
-301,281
Closed -$4.95M
DRI icon
175
Darden Restaurants
DRI
$22.5B
– –
-281,836
Closed -$14.8M
5 6
7
8 9

Similar funds

MWAC
Mariner Wealth Advisors (Cincinnati) Cincinnati, Ohio $1.81B AUM 13.11% 1-Year Est. Return
TP
Tesuji Partners Fort Lee, New Jersey $1.73B AUM 3.93% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
RW
Rand Wealth Baltimore, Maryland $893M AUM 9.85% 1-Year Est. Return
TBC
Three Bays Capital Boston, Massachusetts $848M AUM 7.41% 1-Year Est. Return
BWCA
Brenner West Capital Advisors New York $804M AUM 16.19% 1-Year Est. Return
AC
AFAM Capital Austin, Texas $718M AUM 12.09% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Ascend Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Ascend Capital held 240 positions worth $2.9B, up 11% from $2.61B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ascend Capital deployed $131M of net new capital in Q1 2015, opening 84 new positions and adding to 29 existing holdings. Its largest new stake was Danaher: 1,583,604 shares worth $90.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Huntsman Corp, an estimated $52.6M trimmed.

  • Ascend Capital's largest Q1 2015 buy was Danaher: 1,583,604 shares worth $90.4M.
  • Ascend Capital added most to PPG Industries in Q1 2015, an estimated $64.5M increase.
  • Ascend Capital's biggest Q1 2015 reduction was Huntsman Corp, cutting an estimated $52.6M.
  • Ascend Capital fully exited Andeavor in Q1 2015, selling an estimated $54.1M.
  • Ascend Capital's ten largest holdings make up 25% of its $2.9B portfolio in Q1 2015.
  • Ascend Capital opened 84 new positions and closed 78 in Q1 2015.
  • Ascend Capital's portfolio value rose 11% quarter-over-quarter to $2.9B.

Based on Ascend Capital's 13F filing for Q1 2015, filed 14 May 2015.